St. Jude Medical Inc. (STJ) has garnered Food and Drug Administration approval to launch a trial the company plans to use to pursue U.S. approval for a pacemaker-like device that uses electricity to treat severe depression.
Or on PRInside.com
St. Jude Medical, Inc. Investor Relations Angela Craig, 651-481-7789 or Media Relations Kathleen Janasz, 651-415-7042 or St. Jude Medical, ANS Division Media Relations Denise Landry, 972-309-8085 St. Jude Medical, Inc. (NYSE:STJ) today announced it has received an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin enrollment in a controlled, multi-site, blinded, clinical study
Can someone explain to me why money is involved so explicitly?
Related posts on this blog:
The switch that lifts depression
6 Different locations for deep brain stimulation in depression